Skip to main content
MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED logo

MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED — Investor Relations & Filings

Ticker · MVP ISIN · AU000000MVP2 LEI · 9845007EAECAOD1U4493 ASX Manufacturing
Open in API
Filings indexed 908 across all filing types
Latest filing 2024-04-29 Report Publication Anno…
Country AU Australia
Listing ASX MVP

About MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED

https://medicaldev.com

Medical Developments International Limited specializes in the development and distribution of emergency pain relief and respiratory products. The company's flagship product is Penthrox, a handheld, self-administered inhaler providing rapid-onset, non-opioid analgesia using methoxyflurane. Penthrox is utilized globally by emergency medical services, hospitals, and for procedural pain in various clinical settings. Additionally, the company manufactures a range of respiratory medical devices, including anti-static spacers and asthma management tools designed to optimize medication delivery. The organization focuses on providing portable, effective solutions for acute pain management and respiratory care, catering to healthcare professionals and patients in emergency, surgical, and primary care environments.

Recent filings

Filing Released Lang Actions
Recording of 3Q24 Quarterly Report Investor Presentation 1
Report Publication Announcement Classification · 95% confidence The document is an ASX announcement dated 30 April 2024, titled 'RECORDING OF 3Q24 QUARTERLY REPORT WEBCAST'. It states that a copy of the investor webcast held on 29 April 2024 is now available at the company's presentations page. The document is very short (1376 characters) and does not contain any financial data or detailed report content. It is essentially an announcement about the availability of a webcast recording related to the quarterly report, not the report itself. According to the 'MENU VS MEAL' rule, such a document is classified as a Report Publication Announcement (RPA) rather than an Interim/Quarterly Report (IR).
2024-04-29 English
Appendix 4C & Quarterly Activity Report - 31 March 2024 9 pages 373.3KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Quarterly Activity Report and Appendix 4C for Q3 FY24' and includes detailed financial data such as revenue, cash flows from operating, investing, and financing activities, and cash balances for the quarter ended 31 March 2024. It references Listing Rule 4.7B, which pertains to quarterly cash flow reporting for entities listed on the ASX. The document contains substantive financial data and analysis for a period shorter than a full fiscal year (quarterly). It is not merely an announcement of a report but the report itself with detailed financial statements and operational updates. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q3 2024
2024-04-28 English
Quarterly Report Webcast Details 3Q24 1 page 209.8K
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 29 April 2024, providing details about a webcast for investors to discuss the Quarterly Activity Report for Q3 FY24. It mentions the webcast date, time, and link but does not contain any financial data or the report itself. The document is short (1574 characters) and serves as a notification about the webcast related to the quarterly report rather than the report itself. According to the 'Menu vs Meal' rule, this is an announcement about a report or event, not the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), which covers general regulatory announcements and miscellaneous filings that do not fit other categories.
2024-04-28 English
Quarterly Report Investor Presentation 6 pages 598.4KB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Q3 FY24 QUARTERLY REPORT' and dated 29 April 2024, indicating it covers a quarterly period within fiscal year 2024. It contains detailed financial data such as cash flow statements, operating cashflow commentary, and strategic priorities for the quarter. The length is 8675 characters, which is sufficient to include substantive financial data and analysis. The content includes unaudited quarterly financial information, operational updates, and outlook commentary typical of an interim or quarterly report. There is no indication that this is merely an announcement or a presentation, nor is it a full annual report or earnings release with only highlights. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q3 2024
2024-04-28 English
Change of Director's Interest Notice 2 pages 276.4KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details a director's acquisition of shares, including the number of shares acquired, the price, and the date of change. This is a report of a personal share transaction by a company director. The document length is 3099 characters, which is typical for such notices. There is no indication of financial results, management discussion, or other report types. Therefore, this document fits the definition of 'Director's Dealing' (DIRS).
2024-04-14 English
Change in substantial holding 3 pages 244.0KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 under the Corporations Act 2001 Section 671B, titled 'Notice of Change of Interests of Substantial Holder.' It details changes in voting power and relevant interests of a substantial shareholder (FIL Limited) in Medical Developments International Limited. The content includes dates of changes, nature of changes (buy/sell), and voting power percentages. This type of filing is a notification of changes in significant share ownership levels, which corresponds to the category 'Major Shareholding Notification' (MRQ). The document is not an annual report, earnings release, or any other financial report but a regulatory notice about shareholding changes. The length and detail confirm it is the actual notice, not just an announcement of a report. Therefore, the correct classification is MRQ with high confidence.
2024-03-14 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.